- Home
- category
- DIASAGE (DIABETIC)
- DIASAGE (DIABETIC)
- Empasug 25mg
Empasug 25mg
Manufactured By Intra Life
product type tab
Composition Empagliflozin 25 mg IR
Package SIZE
( 10X10 )
100% Authentic
Products
Free
Shipping
Products
Return Policy
Information about Empasug 25mg
Description:
- Empasug 25mg offers an intensified dose of empagliflozin (25 mg) for patients requiring stronger glycemic control. This once-daily SGLT2 inhibitor is recommended for adults with T2DM and offers added cardiovascular and renal benefits in patients with co-existing heart failure or chronic kidney disease (CKD).
- As a reliable empagliflozin 25mg tablets manufacturer, we ensure each tablet delivers clinically validated performance with consistent formulation quality.
- This product is widely trusted by diabetes medicine distributors for its effectiveness in managing high-risk diabetic cases.
- In addition, we are one of the leading empagliflozin 25mg tablets exporters, meeting global demand with a strong commitment to regulatory compliance.
Key Features:
- Enhanced HbA1c control for patients not achieving targets on lower doses
- Reduces hospitalization for heart failure and CV mortality
- Slows CKD progression by preserving kidney function
- Encourages urinary glucose excretion, improving insulin resistance
- Convenient oral therapy with minimal risk of hypoglycemia
Usage Guidelines:
- Administer once daily, with or without meals
- Appropriate as a step-up therapy from Empasug 10mg
- Requires baseline assessment of kidney function
Safety Profile:
- Common adverse effects include increased urination, genital infections
- Not suitable for patients with severe renal impairment
- Observe for hypovolemia, ketoacidosis, and urinary tract infections
Uses / Indications: Type 2 diabetes mellitus (T2DM) to improve blood sugar control, Heart failure to reduce cardiovascular death and hospitalization, Chronic kidney disease (CKD) to slow progression and lower CV risk.